Approval: 2003 INDICATIONS AND USAGE NAMENDA is an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimers type. (1) DOSAGE AND ADMINISTRATION May be taken with or without food (2) Initial dose is 5 mg once daily. Increase...
1. Indications and Usage for Namenda NAMENDA (memantine hydrochloride) is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. 2. Namenda Dosage and Administration The recommended starting dose of NAMENDA is 5 mg once daily. The dose should be increased in 5 mg...
(memantineHCl)solution,fororaluseInitialU.S.Approval:2003INDICATIONSANDUSAGENAMENDAisanN-methyl-D-aspartate(NMDA)receptorantagonistindicatedforthetreatmentofmoderatetoseveredementiaoftheAlzheimer'stype.(1)DOSAGEANDADMINISTRATIONMaybetakenwithorwithoutfood(2)Initialdoseis5mgoncedaily.Increasedosein5mgincrementstoa...
NAMENDA®and its design are registered trademarks of Merz Pharma GmbH & Co. KGaA. NAM51044_v2 04/17 AbbVie may use and disclose online usage data about you collected automatically through online tracking technologies such as cookies, pixels, and web beacons (collectively, “cookies”). We use...